♟️ Friday 23 October 2026 Fri, 23 Oct 2026

AIC Mines delivered record FY26 revenue, profit and operating cash flow while advancing Jericho and the Eloise processing plant expansion. The growth plan is gaining operational momentum, but it is also increasing debt, execution demands and exposure to copper and diesel prices.

Elixir Energy has agreed to farm out half of its interests across much of the Taroom Trough to Beach Energy for $25 million in cash and a four-year, $180 million gross carried work program. The deal could materially reduce Elixir’s funding burden, but completion still depends on several approvals and conditions.

Element 25 has moved its Butcherbird expansion further into delivery, combining early site works with a binding manganese offtake and a potential AU$50 million project finance package. The project still needs financial close, approvals and major construction contracts before the plan becomes an operating mine.

Beach Energy has agreed to spend A$25 million in cash and carry A$90 million of exploration costs to expand its Taroom Trough footprint to 1,481 km2. The deal gives Beach operatorship of key permits, but remains subject to approvals and pre-emptive rights.

EVT delivered a 17% lift in normalised first-quarter EBITDA to $72.5 million, powered by a sharp recovery in Entertainment and resilient Hotels trading. Thredbo was the drag, while an $800 million property sell-down and ongoing structure review put the group’s Hotels-led strategy under the spotlight.

Aussie Broadband has reaffirmed its FY27 underlying EBITDA guidance of $205 million to $215 million after adding more than 193,000 broadband connections since June. The company says major customer migrations are nearing completion, shifting the focus from scale-building to integration and productivity.

The Takeovers Panel has declined to examine a challenge to Zenith Minerals’ handling of Aurenne’s proposed $5 million funding, removing one regulatory obstacle to Forrestania Resources’ recommended takeover. The Panel said there was no reasonable prospect of declaring unacceptable circumstances, but detailed reasons are still to come.

Zoono Group is seeking up to A$1.61 million from a non-renounceable rights issue after completing a separate A$250,000 placement, with its offer document warning of material uncertainty around going concern. The funds are intended to support shelf-life extension projects, intellectual property and working capital, but investors face dilution and an unresolved legal case.

Hydration Pharmaceuticals is asking eligible shareholders for up to A$1.43 million in fresh capital as it funds the next phase of its turnaround. The non-renounceable offer comes with free options, but is neither underwritten nor subject to a minimum subscription.

Sunrise Energy Metals has completed key Syerston engineering work and received a conditional commitment for up to US$400 million in long-term debt from the U.S. Office of Strategic Capital. The project’s revised scope now carries an estimated A$450 million to A$475 million capital cost, while the proposed Nasdaq redomiciliation remains subject to multiple approvals.

Objective Corporation delivered 9% revenue growth and a 5% lift in net profit for FY2026, but the loss of a long-running Defence agreement and a separate NHVR contract will pressure recurring revenue in the year ahead. Management expects adjusted EBITDA of at least $40 million in FY2027 as it keeps investing in AI, sales capacity and potential acquisitions.

European Resources has lifted bench-scale magnet rare earth extraction at its Korsnäs project to 92% and is moving towards a mixed rare earth carbonate sample for potential customer assessment. The progress comes alongside a new eastern exploration anomaly and a reported cash runway of about two quarters.

Bannerman Energy and CNNC Overseas have approved the Final Investment Decision for the Etango uranium project in Namibia, clearing the way for full-scale construction and targeting first yellowcake in 2028. The project is forecast to produce about 3.5 million pounds of U3O8 annually, with construction funding described as covered by existing cash balances.

PeopleIN improved underlying earnings and reduced leverage in FY26 despite a statutory loss, as Queensland’s infrastructure demand drove a sharp recovery in its core workforce division. The company is now betting that a leaner portfolio, Infrawork’s trans-Tasman labour channel and Brisbane 2032-related work can sustain the upturn.

Equus Energy has secured a binding conditional 10-year gas sales agreement with Alcoa covering about 50 TJ a day, while receiving US$1.5 million to fund the next stage of project partnering. The milestone strengthens the commercial case for the Equus Gas Project, but the development remains pre-FID and requires substantial capital, partners and approvals.

IPD Group closed FY26 with record revenue and earnings, a higher fully franked dividend and leverage of about 0.3 times underlying EBITDA. The electrical infrastructure provider enters FY27 with its data centre pipeline and Platinum Cables integration carrying much of the growth narrative.

Monash IVF Group’s underlying NPAT fell 41% to A$16.1 million in FY26, missing its recently reduced guidance as softer Australian IVF activity outweighed international growth. A second-half market-share recovery, lower planned capital spending and a new productivity program now carry the FY27 investment case.

X2M Connect has secured 60-day exclusivity over a Queensland site for a planned 10MW AI-enabled data centre, with development approval and 2.5MW of grid capacity already in place. The estimated $250 million project could add delivery revenue, recurring platform fees and a potential token revenue share, but key commercial terms remain unresolved.

Paradigm’s administrators have asked the Supreme Court of Western Australia for up to three more months to assess sale and recapitalisation proposals. Without the extension, they say they would have no alternative but to recommend winding up the biotech.

Hawthorn Resources is nearing a financial investment decision on a larger Anglo-Saxon open pit after upgrading the project’s resource to about 200,000 ounces. The opportunity is advancing alongside a wider FY2026 loss, falling cash and pending exploration results at Pinjin East.

Firebrick Pharma is escalating Nasodine’s US push from online sales into retail pharmacies while its September-quarter cash balance fell to A$875,000. The company reported a A$398,000 operating cash outflow and estimated 2.2 quarters of funding at the current rate.

Acusensus has secured a five-year ACT Government traffic enforcement contract valued at approximately $63 million, with extension options that could lift the total to $210 million. The deal broadens its role from specialist detection to a territory-wide enforcement platform, although rollout is not expected until mid-2027.

Fenix Resources has monetised most of its iron ore swap book for more than A$10 million, converting protection on 480,000 tonnes into near-term cash. The move leaves the company retaining diesel and currency hedges while restoring exposure to prevailing iron ore prices on the settled tonnes.

Whitefield Income more than doubled FY2026 profit to $16 million while raising $187 million and maintaining fully franked monthly dividends. Yet net asset backing per share slipped to $1.23 as investment revaluations weighed on equity.